You are required to be logged in to access the full website
Click here if you have forgotten your username or password
18 February 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, on Wednesday announced a research and development agreement with Mayo Clinic to apply artificial intelligence (AI), machine learning (...
18 February 2026 - Clinical-stage biopharmaceutical company Palisade Bio Inc (Nasdaq:PALI) announced on Tuesday the appointment of Bram Verstockt, MD, PhD, to its Clinical Advisory Board.The company said that Dr. Verstockt is an internationally recog...
18 February 2026 - Pre-clinical stage immuno-oncology company Liminatus Pharma Inc (NASDAQ:LIMN) announced on Tuesday the pricing of its best-efforts public offering of 13,813,000 shares of its common stock (or pre-funded warrants in lieu thereof) an...
18 February 2026 - US biotechnology company GelMEDIX Inc announced on Tuesday the completion of a USD13m seed financing led by Safar Partners, with participation from HTL Biotechnology, Beacon Angels, TiE Boston Angels, Boston Harbor Angels, and othe...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe